Arrowhead Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Arrowhead Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Arrowhead Pharmaceuticals Inc.
Rating: 1.905249875
Author: Trendlyne DVM scores

Momentum Trap

about

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed a...

78.03 -1.66 (-2.08%)

New 52W High in past week

357.1K

XNAS Volume

XNAS 15 May, 2026 11:41 AM (EDT)

Board Meeting

The next board meeting for Arrowhead Pharma Inc is on 20 May 2026 for the purpose of 2026 RBC Capital Markets Global Healthcare Conference See details

Low Financial Strength

33.3 / 100

Expensive Valuation

9.8 / 100

Technically Bullish

75.9 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 13%

12 analysts

Arrowhead Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Arrowhead Pharma Inc Live Stock Price Today, Share Analysis and Chart

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed a...

New 52W High in past week

SWOT Analysis

Arrowhead Pharma Inc Live Price Chart